VF
ITRM

Virtu Financial’s Iterum Therapeutics ITRM Stock Holding History

Virtu Financial’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,062
Closed -$7K – 1970
2025
Q4 		$7K Sell
22,062
-25,069
-53% -$13.5K ﹤0.01% 1534
2025
Q3 		$32K Buy
+47,131
New +$36.9K ﹤0.01% 1214
2023
Q1 		– Sell
-23,223
Closed -$20K – 1785
2022
Q4 		$20K Buy
+23,223
New +$33K ﹤0.01% 1270
2022
Q3 		– Sell
-7,365
Closed -$22K – 1961
2022
Q2 		$22K Sell
7,365
-11,491
-61% -$43K ﹤0.01% 1310
2022
Q1 		$100K Sell
18,856
-9,031
-32% -$52.2K 0.01% 971
2021
Q4 		$164K Buy
+27,887
New +$215K 0.02% 913
2021
Q3 		– Sell
-5,577
Closed -$193K – 1718
2021
Q2 		$193K Sell
5,577
-3,303
-37% -$71.6K 0.02% 1011
2021
Q1 		$188K Buy
8,880
+6,006
+209% +$143K 0.01% 1114
2020
Q4 		$43K Buy
+2,874
New +$33.6K ﹤0.01% 1252
2019
Q4 		$101K Buy
+1,493
New +$72.8K 0.01% 1083

Other funds holding ITRM

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial's ITRM Position: Q1 2026 in Review

Virtu Financial sold out of Iterum Therapeutics (ITRM) in Q1 2026, closing a stake of 22,062 shares — an estimated $7K sold.

Virtu Financial first reported a position in ITRM in Q4 2019 and held it in 10 quarters. The position peaked at $193K in Q2 2021. 18 funds tracked by Wall St. Rank hold ITRM as of Q1 2026.

  • Virtu Financial reported no remaining Iterum Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 22,062 Iterum Therapeutics shares in Q1 2026, an estimated $7K.
  • Virtu Financial first reported a position in Iterum Therapeutics in Q4 2019 and held it in 10 quarters.
  • Virtu Financial's Iterum Therapeutics position peaked at $193K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.